{"status": "OK", "response": {"docs": [{"type_of_material": "An Analysis; News Analysis", "blog": [], "news_desk": "National Desk", "lead_paragraph": "From the moment the red light went on last night, Bill Clinton played the optimist and Bob Dole, his Republican rival, played the pessimist. For several months, Mr. Dole's strategists have urged him to project some of the sunniness, some of the confidence that happier days lie just ahead, that made Ronald Reagan one of the great motivators and vote-getters in American history. But Mr. Dole opened the first of his two planned debates with President Clinton by speaking of what he termed the anxieties and worries of the American people, and he said later, ''There's a lot of things wrong with America.''", "headline": {"main": "Is That Glass Half Empty, or Half Full?", "kicker": "POLITICS: NEWS ANALYSIS"}, "abstract": "Perhaps most noteworthy aspect of first Presidential election debate between Pres Clinton and Bob Dole is its temperate and civilized tone; both men stick carefully to major policy issues (M)", "print_page": "1", "word_count": 990, "_id": "4fd1cccf8eb7c8105d703824", "snippet": "From the moment the red light went on last night, Bill Clinton played the optimist and Bob Dole, his Republican rival, played the pessimist.    For several months, Mr. Dole's strategists have urged him to project some of the sunniness, some of the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1996/10/07/us/is-that-glass-half-empty-or-half-full.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CLINTON, BILL"}, {"name": "persons", "value": "DOLE, BOB"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "DEBATING"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 1996"}], "byline": {"person": [{"qualifier": "Jr", "firstname": "R.", "middlename": "W.", "lastname": "APPLE", "rank": 1, "role": "reported", "organization": ""}], "original": "By R. W. APPLE Jr"}, "document_type": "article", "pub_date": "1996-10-07T00:00:00Z", "section_name": "Front Page; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "For the first time in nearly two decades, the rate of births among unmarried women declined in 1995, and for the fourth year in a row the teen-age birth rate dropped, the National Center for Health Statistics said today. The out-of-wedlock birth rate dropped to 44.9 live births per 1,000 unmarried women last year, down from 46.9 births in 1994, a decline of 4 percent, according to a report by the agency, a division of the Centers for Disease Control and Prevention.", "headline": {"main": "U.S. REPORTS DROP IN RATE OF BIRTHS TO UNWED WOMEN"}, "abstract": "Rate of births among unmarried women declines in 1995 for the first time in nearly two decades, and the birth rate for teen-agers also falls--both shifts being part of general decline in nation's birth rate; figures; graph; analysts say drop in out-of-wedlock births is significant even though half the decline stems from changes in reporting births in California; Pres Clinton seizes figures as evidence that his policies are beginning to bear fruit, while Bob Dole says that if Clinton wants credit for this decline, he must also take the blame for rise in teen-age drug use (M)", "print_page": "1", "word_count": 1065, "_id": "4fd1ccce8eb7c8105d70374e", "snippet": "For the first time in nearly two decades, the rate of births among unmarried women declined in 1995, and for the fourth year in a row the teen-age birth rate dropped, the National Center for Health Statistics said today.    The out-of-wedlock birth...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1996/10/05/us/us-reports-drop-in-rate-of-births-to-unwed-women.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CLINTON, BILL"}, {"name": "persons", "value": "DOLE, BOB"}, {"name": "glocations", "value": "CALIFORNIA"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 1996"}, {"name": "subject", "value": "ILLEGITIMACY"}, {"name": "subject", "value": "BIRTHS"}, {"name": "subject", "value": "DRUG ABUSE AND TRAFFIC"}], "byline": {"person": [{"firstname": "Steven", "middlename": "A.", "lastname": "HOLMES", "rank": 1, "role": "reported", "organization": ""}], "original": "By STEVEN A. HOLMES"}, "document_type": "article", "pub_date": "1996-10-05T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Food and Drug Administration today approved a new drug for schizophrenia that doctors said could help patients who do not respond well to existing medicines. The drug, olanzapine, to be sold under the brand name Zyprexa by Eli Lilly & Company, has not yet been adequately compared with existing medicines, and so the agency will not now let the company advertise it as superior.", "headline": {"main": "A New Drug for Schizophrenia Wins Approval From the F.D.A."}, "abstract": "FDA approves new drug for schizophrenia that doctors say could help patients who do not respond well to existing medicines; drug, olanzapine, to be sold under brand name Zyprexa by Eli Lilly & Co, has not yet been adequately compared with existing medicines, and so agency will not now let company advertise it as superior; psychiatrists have high hopes for olanzapine (S)", "print_page": "21", "word_count": "435", "_id": "4fd1cccb8eb7c8105d7034af", "snippet": "The Food and Drug Administration today approved a new drug for schizophrenia that doctors said could help patients who do not respond well to existing medicines.    The drug, olanzapine, to be sold under the brand name Zyprexa by Eli Lilly & Company,...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1996/10/02/us/a-new-drug-for-schizophrenia-wins-approval-from-the-fda.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "LILLY, ELI, & CO"}, {"name": "subject", "value": "OLANZAPINE (DRUG)"}, {"name": "subject", "value": "SCHIZOPHRENIA"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ZYPREXA (DRUG)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}], "byline": null, "document_type": "article", "pub_date": "1996-10-02T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Harvard University is paying $775,000 to settle Federal claims of lax security and faulty record keeping that led to drug thefts at the university pharmacy used by its students, faculty members and staff, the United States Attorney in Massachusetts announced today. The settlement, under the Controlled Substances Act, is the second largest of its kind in the nation and the largest involving a single pharmacy, said Donald Stern, the United States Attorney here. The pharmacy, part of a campus health services office in Harvard Square, is owned and operated by the university.", "headline": {"main": "Harvard Pays $775,000 to Settle Suit Over Laxness at Pharmacy"}, "abstract": "Harvard University is paying $775,000 to settle Federal claims of lax security and faulty record keeping that led to drug thefts at university pharmacy in Harvard Square (S)", "print_page": "19", "word_count": 560, "_id": "4fd1f3828eb7c8105d74b998", "snippet": "Harvard University is paying $775,000 to settle Federal claims of lax security and faulty record keeping that led to drug thefts at the university pharmacy used by its students, faculty members and staff, the United States Attorney in Massachusetts...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1996/10/01/us/harvard-pays-775000-to-settle-suit-over-laxness-at-pharmacy.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "HARVARD UNIVERSITY"}, {"name": "subject", "value": "ROBBERIES AND THEFTS"}, {"name": "subject", "value": "FINES (PENALTIES)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "SECURITY AND WARNING SYSTEMS"}], "byline": null, "document_type": "article", "pub_date": "1996-10-01T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 4, "offset": 0, "time": 40}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}